GIFLF:OTCMKTS
Grifols SA Class A
US$11,13
0,00%
(0,00) 1 HR
15 Sep, 15.11.14 GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk GIFLF...
Kapitalisasi pasar
6,58 M
Volume rata-rata
543,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
US$12,90
Harga rendah dalam 52 minggu terakhir
US$10,13
Beta
0,90
Saham beredar
426,13 jt
Jumlah karyawan
25 rb
Kapitalisasi pasar
6,58 M
Volume rata-rata
543,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
US$12,90
Harga rendah dalam 52 minggu terakhir
US$10,13
Beta
0,90
Saham beredar
426,13 jt
Jumlah karyawan
25 rb
Artikel berita
Dari sumber web dan partner berita
AD HOC NEWS
·
18 jam yang lalu
Grifols stock gains as H1 profit rises 28.7 percent
AD HOC NEWS
·
18 jam yang lalu
Grifols stock after-hours at EUR 9.65: plus 1.37 percent versus prior close
The New York Times
·
1 bulan yang lalu
After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Tentang Grifols SA Class A